Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial.

There was a difference between the groups for mean number of years with a diagnosis of MS ( p = 0.01) and for baseline DGI, although the latter did not reach statistical significance.

also in 111,027 other papers